The combination of hormone replacement and cancer, particularly breast cancer, is a seemingly "obvious" medical contradiction. But yet, is it possible that it may be the "right thing to do" for some or even most people? In my opinion, yes. Cancer therapies challenge good health and, simultaneously, age people. Yes, it  is true, that many survive to live longer lives than expected, but for many, the quality of life and their current existence is colorless, uncomfortable, and  less than "alive". It is The Wiley Protocol, as an adjuvant therapy, that has had the most positive impact on my patients, who have either asked for this specific Protocol or who have begged for the opportunity to feel better with any unconventional treatment.

I have been monitoring this mode of hormone replacement since 2002, and most women have noted impressive changes not seen with standard treatment. The consistent theme from women with, either active or history of breast cancer, is,' I'd rather risk living a shorter life using this hormone Protocol than a longer one without it". This is their informed choice, their life, and their responsibility.

In November 2006, I will be reporting on 53 women ( 47 with oncology diagnoses : 28 breast cancer and 5 DCIS : 10 other) who started the Wiley protocol and the positive and negative issues involved. So far the adverse events are:

1) one 71 year old woman who had been on the WP for 3 years survived non-critical shower pulmonary embolisms and who insisted continuing her Wiley Protocol at a reduced dose with her anti-coagulation meds because it helped her with her debilitating arthritis, mood, engery better than other medications.

2) A 57 year old chest-wall relapse at the mastectomy site for stage IIB disease after using the hormones for 3 years. The lesion was removed, and the patient insists on continuing WP.

3) A new breast cancer (stage1B) discovered < 2 years after using the protocol in a 58 year old. This mirrored breast cancer was present at the same time her original breast cancer was diagnosed, but was detected on mammography about a year and a half later and observed radiographically until biopsy.

Even I, as a principal investigator for many clinical oncology trials producing evidence-based data, made the leap and began using the unconventional, unstudied Wiley Protocol for my own medical issues.
It was that month when I began to heal.....and began to investigate more.

Julie A. Taguchi Biography

Julie Taguchi, M.D., an oncologist, is a staff physician at Sansum Medical Clinic in Santa Barbara. She joined the team for the Wiley Protocol to clinically test their progesterone theories at Cottage Hospital in 1999.

• Sansum Clinic, 317 West Pueblo St., Santa Barbara, CA 93105

Specialty Department(s)

• Oncology/Hematology

Education

• BS Mount St. Mary's College – summa cum laude
• MD, University of Southern California
• Internship, Kaiser Foundation Hospital, Los Angeles
• Residency, Kaiser Foundation Hospital, Los Angeles
• Fellowship, Hematology, Kaiser Foundation Hospital, Los Angeles
• Fellowship, Oncology, University of Southern California

Board Certification(s)

• Hematology, American Board of Internal Medicine
• Internal Medicine, American Board of Internal Medicine
• Medical Oncology, American Board of Internal Medicine
  

 Affiliations

• Member, American College of Physicians - American Society of Internal Medicine
• Member, American Society of Clinical Oncology
• Member, American Society of Hematology
• Member, Santa Barbara County Medical Society
• Member, American College for the Advancement of Medicine
  

Staff physician – Department of Hematology and Bone Marrow Transplantation: City of Hope 1990-1992

Principal Investigator for Sansum’s clinical oncology research program

• Board of Directory, Tri-counties Blood Bank

• 1991

• 1993